Integrated high-throughput analysis identifies super enhancers associated with chemoresistance in SCLC.
Jiarong BaoMan LiShumei LiangYunchu YangJingfang WuQingqing ZouShun FangSize ChenLinlang GuoPublished in: BMC medical genomics (2019)
We screened out SEs involved with drug resistance and evaluated the functions of FOXP1, IRF1, and SP1 in chemoresistance. Our findings established a large group of SEs associated with drug resistance in small cell lung cancer, revealed the drug resistance mechanisms of SEs, and provided insights into the clinical applications of SEs.